Vaishali Pharma Annualised Returns
Vaishali Pharma Annualised Returns
Vaishali Pharma Share Price Today
Vaishali Pharma Share Price Today
As of 1 Nov 2026, Vaishali Pharma share price is ₹6.4. The stock opened at ₹6.8 and had closed at ₹6.8 the previous day. During today’s trading session, Vaishali Pharma share price moved between ₹6.35 and ₹6.90, with an average price for the day of ₹6.63. Over the last 52 weeks, the stock has recorded a low of ₹4.75 and a high of ₹10.48. In terms of performance, Vaishali Pharma share price has declined by 15.6% over the past six months and has declined by 32.27% over the last year.
Vaishali Pharma Stock Performance
Vaishali Pharma Share Price Chart
Vaishali Pharma Share Price Chart
Vaishali Pharma Company background
Vaishali Pharma Limited was originally incorporated as a Private Limited Company with the name Vaishali Pharma Private Limited on 25th, April 2008. On July 01, 2008 the Company acquired the business of proprietorship concerns of its Promoter Mr. Atul Vasani viz. M/s. Vaishali Pharmachem through Business Assignment agreement. Consequently, the business of said Proprietorship Firm merged into Vaishali Pharma Private Limited. Subsequently, the Company converted into a Public Limited Company and the name was changed to Vaishali Pharma Limited on 21st, June 2017. Atul Vasani and Jagruti Vasani are the Promoters of the Company.Vaishali Pharma is a pharmaceutical company, dealing in pharmaceutical formulations, APIs, surgical products, veterinary supplements, herbal nutraceutical products. The Company is operating both in domestic and export markets. In domestic markets, it is majorly into trading of APIs whereas in export markets, it is into trading and marketing of APIs, formulations, surgical products and others. For the export markets, the Company gets the formulations whose facilities are approved and certified by respective countries for developing the products. The Company has over 250 + formulation brands marketed in multiple countries of which dossier is in CTD format along with itsrespective bioequivalence. The Company built a robust pipeline of around 250 Dossiers. The Companys synergistic collaboration with WHOGMP manufacturing facilities is backed by an excellent rapport with clients.In 2012, the Company ventured into new Vertical in Formulation Manufacturing and Exports. In 2016, it introduced a vertical of Surgical Division. The Company obtained ISO 9001:2015 Certification for the Quality Management System from Deutsche Accreditation Board, Germany and ISC Global, Dubai, UAE. It is also certified by European Certification Organisation and Compliance Certificate with regards to Council Directive relating to Surgical Instruments Medical Devices Directive. In addition, the Company has also been recognized by Government of India as One Star Export House and holds a valid certificate for the same from the Director General of Foreign Trade in 2017. In August 2017, Company came up with an Initial Public Offer consisting of Fresh Issue of 19,76,000 Equity Shares by raising capital aggregating Rs 14.22 Crore.
Vaishali Pharma Financial Highlights
For Q1 FY2026–2027, Vaishali Pharma's revenue reached ₹23.47 crore and profit touched at ₹1.55 crore. As of 1 November 2026, Vaishali Pharma’s market capitalization reached at ₹86.67 crores. Shareholding as of 1 November 2026 shows promoters holding 31.6% and public at 68.4%.
Vaishali Pharma Fundamental
Market Cap (in crs)
86.67
Face Value
2
Turnover (in lacs)
12.00
Key Metrics
Vaishali Pharma Key Financials
View moreVaishali Pharma Result Highlights
- Vaishali Pharma reported a 16.7% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Jun (Q1 FY 2026-27). On a year-on-year (YoY) basis, it witnessed a decline of 4.6%.
- Its expenses for the quarter were down by 22.3% QoQ and 4.8% YoY.
- The net profit increased 307.9% QoQ and increased 21.1% YoY.
- The earnings per share (EPS) of Vaishali Pharma stood at 0.12 during Q1 FY 2026-27.
Data Source: BSE, Company announcements
The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.
Vaishali Pharma Technical Analysis
Delivery & Volume
Delivery Volume %
Day
70.60%
Week
67.20%
Month
65.90%
Resistance & Support
Vaishali Pharma Peer comparison
CompareIndex Name | Market Price |
|---|---|
48.38 -0.61 (-1.25%)▼ | |
27.72 -0.70 (-2.46%)▼ | |
61.20 -0.43 (-0.70%)▼ | |
790.00 +56.00 (+7.63%)▲ | |
63.55 -2.44 (-3.70%)▼ | |
120.80 +5.00 (+4.32%)▲ |
Vaishali Pharma Share Price FAQs
Vaishali Pharma Ltd share price in the past 1-year return was -36.24. The Vaishali Pharma Ltd share hit a 1-year low of Rs. 4.75 and a 1-year high of Rs. 10.48.
The market cap of Vaishali Pharma Ltd is Rs. 86.67 Cr. as of 30/10/2026.
The PE ratios of Vaishali Pharma Ltd is 20.71 as of 30/10/2026.
The PB ratios of Vaishali Pharma Ltd is 1.11 as of 30/10/2026
You can easily buy Vaishali Pharma Ltd shares in Kotak Neo by opening a demat account and getting the KYC documents verified online.
The 52-week high and low of Vaishali Pharma Ltd share price is ₹10.48 and ₹4.75 as of 30/10/2026.
Please be aware that Vaishali Pharma Ltd stock prices are subject to continuous fluctuations due to various factors.